Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ACLX Arcellx
31.390-0.500-1.57%
Trading Session
02/08 12:29 ET
High
31.850
Open
31.850
Turnover
3.36M
Low
31.000
Pre Close
31.890
Volume
107.23K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Arcellx to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Feb. 2, 2023 /PRNewswire/ -- Arcellx, Inc. (NASDAQ:ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other
Arcellx (NASDAQ:ACLX) Sets New 1-Year High at $35.16
Arcellx, Inc. (NASDAQ:ACLX – Get Rating)'s stock price reached a new 52-week high during trading on Monday . The company traded as high as $35.16 and last traded at $33.14, with a volume of 37379 sha
Gilead, Arcellx Close Agreement on Developing T-cell Therapy for Multiple Myeloma
Kite and Arcellx Close Pact to Develop Late-stage Clinical CART-ddBCMA in MM
Arcellx, Inc. (NASDAQ:ACLX) Major Shareholder Scott D. Sandell Sells 390 Shares
Arcellx, Inc. (NASDAQ:ACLX – Get Rating) major shareholder Scott D. Sandell sold 390 shares of Arcellx stock in a transaction on Friday, December 23rd. The shares were sold at an average price of $31
Reviewing Arcellx (NASDAQ:ACLX) & Achilles Therapeutics (NASDAQ:ACHL)
Arcellx (NASDAQ:ACLX – Get Rating) and Achilles Therapeutics (NASDAQ:ACHL – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
Have Arcellx, Inc. (NASDAQ:ACLX) Insiders Been Selling Their Stock?
We note that a Arcellx, Inc. (NASDAQ:ACLX) insider, Forest Baskett, recently sold US$51k worth of stock for US$31.45 per share. On the bright side, that's just a small sale and only reduced their h
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.Axcella Heal
Head-To-Head Contrast: Arcellx (NASDAQ:ACLX) Versus Freeline Therapeutics (NASDAQ:FRLN)
Arcellx (NASDAQ:ACLX – Get Rating) and Freeline Therapeutics (NASDAQ:FRLN – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on
Arcellx (NASDAQ:ACLX) Price Target Raised to $35.00 at Needham & Company LLC
Arcellx (NASDAQ:ACLX – Get Rating) had its price target hoisted by Needham & Company LLC from $31.00 to $35.00 in a research note issued to investors on Monday, The Fly reports. The brokerage current
Company Overview
More
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
CEO： Mr. Rami Elghandour
Market： NASDAQ
Listing Date： 02/04/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet